We are democratizing ECG to improve cardiac care at home.

Tech Brief

Conventional 12-lead ECG is a complex procedure that needs to be performed by a trained technician thus only available in hospitals and doctor's offices. QT Medical has reinvented the ECG to make it so simple that anyone, with no training or experience, can complete a medical standard 12-lead ECG test in the comfort of their homes. This is a complete remote ECG platform that includes a prepositioned and preconnected electrode strip, a supercompact ECG recorder (world's smallest 12-lead ECG device), an app on smartmobile devices, HIPAA-coompliant cloud server and computer diagnostics soon to be powered by machine learning. We conducted a clinical trial to show that this ECG, depsite being small and simple, produces ECGs the same quality as the market leader Philip's ECG systems. Furthermore, we have proven that over 98% patients, with no training, can complete the test with good quality ECGs uploaded to the cloud for the doctors to review.

Problem Tech Solves

Our technology focus is on electrocardiogram (ECG or EKG), and our goal is to make hospital grade 12-lead ECG available and affordable to everyone. ECG is the most used test for the heart, and the third most commonly ordered medical test. Over 350 million resting ECG tests are performed worldwide each year. Conventional 12-lead ECG has to be performed by medical professionals in hospitals. QT Medical’s first product, PCA 500, is a medical standard 12-lead ECG approved by the FDA for professional and patient use. PCA 500 is now in use on airplanes, in clinics, hospitals, CROs, schools, prisons and by patients at home. In response to the needs in the pandemic, QT Medical created a revolutionary business model by offering the world’s only mail delivery 12-lead ECG test for patients at home—Xpress ECG.


Xpress ECG is the only mail delivery home 12-lead ECG test available. We have served over 3000 patients. The results from the first 1000 patients are recently published in the Journal of Electrocardiology. Over 98% patients completed their tests successfully without technical problems. The paper can be downloded here: https://www.sciencedirect.com/science/article/pii/S0022073622000863?via%3Dihub